par Journé, Fabrice ;Kheddoumi, Naima ;Chaboteaux, Carole ;Duvillier, Hugues ;Laurent, Guy ;Body, Jean-Jacques
Référence Breast cancer research, 10, 1, page (R4)
Publication Publié, 2008
Référence Breast cancer research, 10, 1, page (R4)
Publication Publié, 2008
Article révisé par les pairs
Résumé : | Bisphosphonates have become standard therapy for the treatment of skeletal complications related to breast cancer. Although their therapeutic effects mainly result from an inhibition of osteoclastic bone resorption, in vitro data indicate that they also act directly on breast cancer cells, inhibiting proliferation and inducing apoptosis. |